6.08
6.08 (0%)
As of Feb 14, 2025
Jasper Therapeutics, Inc. [JSPR]
Source:
Company Overview
Jasper Therapeutics, Inc is a clinical-stage biotechnology companyfocused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (“CSU”), ChronicInducible Urticaria (“CIndU”) and Asthma.
Country | United States |
Headquarters | redwood city, california |
Phone Number | 6505491400 |
Industry | finance |
CEO | Ronald Martell |
Website | www.jaspertherapeutics.com |